Mathematical model of triple-negative breast cancer in response to combination chemotherapies
From MaRDI portal
Publication:2111185
DOI10.1007/S11538-022-01108-1zbMATH Open1505.92095OpenAlexW4312106330MaRDI QIDQ2111185FDOQ2111185
Publication date: 28 December 2022
Published in: Bulletin of Mathematical Biology (Search for Journal in Brave)
Full work available at URL: https://doi.org/10.1007/s11538-022-01108-1
Cites Work
- Making best use of model evaluations to compute sensitivity indices
- Global sensitivity indices for nonlinear mathematical models and their Monte Carlo estimates
- Macrophage-tumour interactions: In vivo dynamics
- Nonlinear simulation of the effect of microenvironment on tumor growth
- Sensitivity measures,anova-like Techniques and the use of bootstrap
- A mathematical model of breast cancer treatment with CMF and doxorubicin
- A reduced mathematical model of the acute inflammatory response. I: Derivation of model and analysis of anti-inflammation
- A reduced mathematical model of the acute inflammatory response. II: Capturing scenarios of repeated endotoxin administration
- A framework for model analysis across multiple experiment regimes: investigating effects of zinc on \textit{Xylella fastidiosa} as a case study
- Mathematical modelling of trastuzumab-induced immune response in an in vivo murine model of HER2+ breast cancer
- Mathematical modeling of therapeutic neural stem cell migration in mouse brain with and without brain tumors
Cited In (7)
- Mathematical model for the estrogen paradox in breast cancer treatment
- A mathematical model for the effects of HER2 overexpression on cell proliferation in breast cancer
- A mathematical model of breast cancer treatment with CMF and doxorubicin
- Model selection for assessing the effects of doxorubicin on triple-negative breast cancer cell lines
- Title not available (Why is that?)
- Data-based modeling of breast cancer and optimal therapy
- Optimizing combination therapy in a murine model of HER2+ breast cancer
Recommendations
- Model selection for assessing the effects of doxorubicin on triple-negative breast cancer cell lines 👍 👎
- A PROGNOSTIC IMMUNOTHERAPY MODEL FOR 4T1 BREAST CANCER WITH COMBINED CYCLOPHOSPHAMIDE AND TLR AGONIST 👍 👎
- Mathematical modeling of ER-positive breast cancer treatment with AZD9496 and palbociclib 👍 👎
- Mathematical modelling of trastuzumab-induced immune response in an in vivo murine model of HER2+ breast cancer 👍 👎
- Optimizing combination therapy in a murine model of HER2+ breast cancer 👍 👎
This page was built for publication: Mathematical model of triple-negative breast cancer in response to combination chemotherapies
Report a bug (only for logged in users!)Click here to report a bug for this page (MaRDI item Q2111185)
